|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1200 New York Avenue, NW, Suite 550 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 40048368-12
|
||||||||
|
6. House ID# 401260000
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Michael Owens |
Date | 10/21/2016 8:05:38 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
H.R. 9 Innovation Act
H.R. 2045 Targeting Rogue and Opaque Letters Act of 2015
H.R. 4829 Trade Protection Not Troll Protection Act
S.632 STRONG Patents Act of 2015
S.779 Fair Access to Science and Technology Research Act
S.1137 PATENT Act
S.1890 Defend Trade Secrets Act of 2016
S.2733 Venue Equity and Non-Uniformity Elimination Act
S.2852 OPEN Government Data Act
-- regarding the effect on higher education institutions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jessica |
Sebeok |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 5054 FY17 Agriculture Appropriations
H.R. 5055 FY17 Energy and Water Development Appropriations
H.R. 5293 FY17 Defense Appropriations
H.R. 5325 FY17 Continuing Resolution
H.R. 5393 FY17 Commerce, Justice, Science Appropriations
H.R. 5538 FY17 Interior and Environment Appropriations Bill
H.R. 5926 FY17 Labor-HHS-Education Appropriations Bill
S. 2837 FY17 Commerce, Justice, Science Appropriations
S. 2943 National Defense Authorization Act
S. 2956 FY17 Agriculture Appropriations
S. 3040 FY17 Labor-HHS-Education Appropriations Bill
S. 3068 FY17 Interior and Environment Appropriations Bill
-- regarding funding for higher education and research programs and agencies.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Owens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S.108 Financial Aid Simplification and Transparency Act
-- regarding higher education policy issues.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Owens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
HR. 8 North American Energy Security and Infrastructure Act
H.R. 1806 America COMPETES Act Reauthorization Act
H.R. 3537 Synthetic Drug Control Act
H.R. 4783 Commercializing on Small Business Innovation Act
H.R. 4909 National Defense Authorization Act
H.R. 5583 University Regulation Streamlining and Harmonization Act
S. 3346 The NASA Transition Authorization Act
S. 185 Promise for Antibiotics and Therapeutics for Health Act
S. 771 Manufacturing Universities Act
S. 2012 Energy Policy and Modernization Act
S. 2089 American Energy Innovation Act
S. 2658 Federal Aviation Administration (FAA) Modernization Act
S. 2713 Advancing Precision Medicine Act of 2016
S. 2742 Promoting Biomedical Research and Public Health for Patients Act
S. 2745 Advancing NIH Strategic Planning and Representation in Medical Research Act
S. 2793 SBIR/STTR Reauthorization Act
S. 2812 SBIR and STTR Reauthorization and Improvement Act
S. 2898 Small Business National Security Innovation Act
S. 2943 National Defense Authorization Act
S. 3084 American Innovation and Competitiveness Act
S. 3224 Synthetic Drug Control Act
-- regarding research-related funding and policy issues affecting higher education institutions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Owens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |